36289519|t|GSK872 and necrostatin-1 protect retinal ganglion cells against necroptosis through inhibition of RIP1/RIP3/MLKL pathway in glutamate-induced retinal excitotoxic model of glaucoma.
36289519|a|BACKGROUND: Glaucoma, the major cause of irreversible blindness worldwide, is characterized by progressive degeneration of retinal ganglion cells (RGCs). Current treatments for glaucoma only slow or partially prevent the disease progression, failing to prevent RGCs death and visual field defects completely. Glutamate excitotoxicity via N-methyl-D-aspartic acid (NMDA) receptors plays a vital role in RGCs death in glaucoma, which is often accompanied by oxidative stress and NLRP3 inflammasome activation. However, the exact mechanisms remain unclear. METHODS: The glutamate-induced R28 cell excitotoxicity model and NMDA-induced mouse glaucoma model were established in this study. Cell counting kit-8, Hoechst 33342/PI dual staining and lactate dehydrogenase release assay were performed to evaluate cell viability. Annexin V-FITC/PI double staining was used to detect apoptosis and necrosis rate. Reactive oxygen species (ROS) and glutathione (GSH) were used to detect oxidative stress in R28 cells. Levels of proinflammatory cytokines were measured by qRT-PCR. Transmission electron microscopy (TEM) was used to detect necroptotic morphological changes in RGCs. Retinal RGCs numbers were detected by immunofluorescence. Hematoxylin and eosin staining was used to detect retinal morphological changes. The expression levels of RIP1, RIP3, MLKL and NLRP3 inflammasome-related proteins were measured by immunofluorescence and western blotting. RESULTS: We found that glutamate excitotoxicity induced necroptosis in RGCs through activation of the RIP1/RIP3/MLKL pathway in vivo and in vitro. Administration of the RIP3 inhibitor GSK872 and RIP1 inhibitor necrostatin-1 (Nec-1) prevented glutamate-induced RGCs loss, retinal damage, neuroinflammation, overproduction of ROS and a decrease in GSH. Furthermore, after suppression of the RIP1/RIP3/MLKL pathway by GSK872 and Nec-1, glutamate-induced upregulation of key proteins involved in NLRP3 inflammasome activation, including NLRP3, pro-caspase-1, cleaved-caspase-1, and interleukin-1beta (IL-1beta), was markedly inhibited. CONCLUSIONS: Our findings suggest that the RIP1/RIP3/MLKL pathway mediates necroptosis of RGCs and regulates NLRP3 inflammasome activation induced by glutamate excitotoxicity. Moreover, GSK872 and Nec-1 can protect RGCs from necroptosis and suppress NLRP3 inflammasome activation through inhibition of RIP1/RIP3/MLKL pathway, conferring a novel neuroprotective treatment for glaucoma.
36289519	0	6	GSK872	Chemical	MESH:C000633405
36289519	11	24	necrostatin-1	Chemical	MESH:C507699
36289519	33	49	retinal ganglion	Disease	MESH:D012173
36289519	98	102	RIP1	Gene	19766
36289519	103	107	RIP3	Gene	116504
36289519	108	112	MLKL	Gene	74568
36289519	124	133	glutamate	Chemical	MESH:D018698
36289519	142	161	retinal excitotoxic	Disease	MESH:D012173
36289519	171	179	glaucoma	Disease	MESH:D005901
36289519	193	201	Glaucoma	Disease	MESH:D005901
36289519	235	244	blindness	Disease	MESH:D001766
36289519	304	320	retinal ganglion	Disease	MESH:D012173
36289519	358	366	glaucoma	Disease	MESH:D005901
36289519	457	477	visual field defects	Disease	MESH:D005128
36289519	490	499	Glutamate	Chemical	MESH:D018698
36289519	500	514	excitotoxicity	Disease	
36289519	597	605	glaucoma	Disease	MESH:D005901
36289519	658	663	NLRP3	Gene	287362
36289519	748	757	glutamate	Chemical	MESH:D018698
36289519	766	769	R28	CellLine	CVCL:D502
36289519	775	789	excitotoxicity	Disease	
36289519	813	818	mouse	Species	10090
36289519	819	827	glaucoma	Disease	MESH:D005901
36289519	887	900	Hoechst 33342	Chemical	MESH:C017807
36289519	1068	1076	necrosis	Disease	MESH:D009336
36289519	1083	1106	Reactive oxygen species	Chemical	MESH:D017382
36289519	1108	1111	ROS	Chemical	MESH:D017382
36289519	1117	1128	glutathione	Chemical	MESH:D005978
36289519	1130	1133	GSH	Chemical	MESH:D005978
36289519	1175	1178	R28	CellLine	CVCL:D502
36289519	1407	1418	Hematoxylin	Chemical	MESH:D006416
36289519	1513	1517	RIP1	Gene	19766
36289519	1519	1523	RIP3	Gene	116504
36289519	1525	1529	MLKL	Gene	74568
36289519	1534	1539	NLRP3	Gene	216799
36289519	1651	1660	glutamate	Chemical	MESH:D018698
36289519	1661	1675	excitotoxicity	Disease	
36289519	1730	1734	RIP1	Gene	19766
36289519	1735	1739	RIP3	Gene	116504
36289519	1740	1744	MLKL	Gene	74568
36289519	1797	1801	RIP3	Gene	116504
36289519	1812	1818	GSK872	Chemical	MESH:C000633405
36289519	1823	1827	RIP1	Gene	19766
36289519	1838	1851	necrostatin-1	Chemical	MESH:C507699
36289519	1853	1858	Nec-1	Chemical	MESH:C507699
36289519	1870	1879	glutamate	Chemical	MESH:D018698
36289519	1888	1897	RGCs loss	Disease	MESH:D012173
36289519	1899	1913	retinal damage	Disease	MESH:D012164
36289519	1915	1932	neuroinflammation	Disease	MESH:D000090862
36289519	1952	1955	ROS	Chemical	MESH:D017382
36289519	1974	1977	GSH	Chemical	MESH:D005978
36289519	2017	2021	RIP1	Gene	19766
36289519	2022	2026	RIP3	Gene	116504
36289519	2027	2031	MLKL	Gene	74568
36289519	2043	2049	GSK872	Chemical	MESH:C000633405
36289519	2054	2059	Nec-1	Chemical	MESH:C507699
36289519	2061	2070	glutamate	Chemical	MESH:D018698
36289519	2120	2125	NLRP3	Gene	287362
36289519	2161	2166	NLRP3	Gene	287362
36289519	2172	2181	caspase-1	Gene	25166
36289519	2191	2200	caspase-1	Gene	25166
36289519	2206	2223	interleukin-1beta	Gene	24494
36289519	2225	2233	IL-1beta	Gene	24494
36289519	2303	2307	RIP1	Gene	19766
36289519	2308	2312	RIP3	Gene	116504
36289519	2313	2317	MLKL	Gene	690743
36289519	2369	2374	NLRP3	Gene	287362
36289519	2410	2419	glutamate	Chemical	MESH:D018698
36289519	2420	2434	excitotoxicity	Disease	
36289519	2446	2452	GSK872	Chemical	MESH:C000633405
36289519	2457	2462	Nec-1	Chemical	MESH:C507699
36289519	2510	2515	NLRP3	Gene	287362
36289519	2562	2566	RIP1	Gene	19766
36289519	2567	2571	RIP3	Gene	116504
36289519	2572	2576	MLKL	Gene	690743
36289519	2635	2643	glaucoma	Disease	MESH:D005901
36289519	Association	MESH:D012173	19766
36289519	Negative_Correlation	MESH:C507699	19766
36289519	Positive_Correlation	MESH:D018698	MESH:D000090862
36289519	Positive_Correlation	MESH:D017382	MESH:D018698
36289519	Negative_Correlation	MESH:C507699	MESH:D018698
36289519	Negative_Correlation	MESH:C000633405	MESH:D012164
36289519	Negative_Correlation	MESH:C507699	116504
36289519	Positive_Correlation	MESH:C507699	24494
36289519	Negative_Correlation	MESH:C000633405	24494
36289519	Negative_Correlation	MESH:C507699	MESH:D005978
36289519	Negative_Correlation	MESH:C000633405	19766
36289519	Positive_Correlation	MESH:D018698	24494
36289519	Negative_Correlation	MESH:C000633405	MESH:D012173
36289519	Negative_Correlation	MESH:C507699	25166
36289519	Positive_Correlation	MESH:D018698	MESH:D012173
36289519	Association	MESH:D005978	116504
36289519	Association	25166	74568
36289519	Positive_Correlation	MESH:D018698	116504
36289519	Negative_Correlation	MESH:C507699	MESH:D012173
36289519	Negative_Correlation	MESH:C000633405	MESH:D018698
36289519	Negative_Correlation	MESH:C507699	MESH:D000090862
36289519	Negative_Correlation	MESH:C000633405	116504
36289519	Positive_Correlation	MESH:D018698	MESH:D012164
36289519	Positive_Correlation	MESH:D018698	74568
36289519	Negative_Correlation	MESH:C000633405	74568
36289519	Positive_Correlation	MESH:D018698	287362
36289519	Association	MESH:D018698	MESH:D005901
36289519	Negative_Correlation	MESH:C507699	287362
36289519	Association	MESH:D017382	116504
36289519	Negative_Correlation	MESH:C000633405	MESH:D017382
36289519	Negative_Correlation	MESH:C000633405	25166
36289519	Positive_Correlation	MESH:D018698	19766
36289519	Negative_Correlation	MESH:C000633405	MESH:D000090862
36289519	Positive_Correlation	MESH:D018698	25166
36289519	Association	MESH:D005901	287362
36289519	Negative_Correlation	MESH:C507699	MESH:D017382
36289519	Negative_Correlation	MESH:C507699	MESH:D012164
36289519	Association	MESH:D012173	116504
36289519	Negative_Correlation	MESH:C000633405	MESH:D005978
36289519	Negative_Correlation	MESH:C507699	74568

